---
title: KBI Biopharma, Inc. vs Richter BioLogics
slug_a: kbibiopharma
slug_b: richterbiologics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/kbibiopharma/richterbiologics
generated_by: BioBM Editorial AI
---

# KBI Biopharma, Inc. vs Richter BioLogics

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

KBI Biopharma, Inc. (kbibiopharma) is listed for cdmo. Global CDMO offering cell line development, process and analytical development, formulation development, and clinical and commercial manufacturing for mammalian and microbial biologics.

Services: 13. Modalities: 2. Indications: 1. Locations: 11. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (13).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Richter BioLogics (richterbiologics) is listed for cdmo. Germany-based CDMO specializing in GMP-compliant microbial production of recombinant proteins, peptides, plasmid DNA, and bacterial vaccines with bioreactor capacity up to 1,500 litres and regulatory clearance from FDA, EMA, ANVISA, PMDA, and MFDS.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 4. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.